Hugues Chanteux
- Molecular Medicine top 5%
- Pharmacology top 1%
- Pharmacogenetics and Drug Metabolism 9
- Antibiotics Pharmacokinetics and Efficacy 8
- Drug-Induced Hepatotoxicity and Protection 3
- Hepatology top 5%
- Psychiatry and Mental health top 5%
- Epilepsy research and treatment 12
-
- Pharmacological Effects and Toxicity Studies 15
- Pharmaceutical studies and practices 3
-
- Drug Transport and Resistance Mechanisms 12
-
- Neuroscience and Neuropharmacology Research 5
- Co-authors
- Brigitte GerinPaul M. TulkensMarie‐Paule Mingeot‐LeclercqFranck A. AtienzarKaren TilmantB. O. DepelchinHelga H.J. GeretsStéphane Dhalluin
- Partner nations
- BelgiumUnited KingdomUnited States
In The Last Decade
Hugues Chanteux
38 papers receiving 1.7k citations
Hit Papers
Peers
Comparison fields: 5 of 124
- Molecular Medicine 162
- Pharmacology 276
- Hepatology 171
- Psychiatry and Mental health 291
- Applied Microbiology and Biotechnology 38
Countries citing papers authored by Hugues Chanteux
This map shows the geographic impact of Hugues Chanteux's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hugues Chanteux with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hugues Chanteux more than expected).
Fields of papers citing papers by Hugues Chanteux
This network shows the impact of papers produced by Hugues Chanteux. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hugues Chanteux. The network helps show where Hugues Chanteux may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hugues Chanteux, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 1 | |
| 2 | 2023 | 4 | |
| 3 | 2020 | 3 | |
| 4 | 2020 | 12 | |
| 5 | 2020 | 39 | |
| 6 | 2019 | 3 | |
| 7 | 2018 | 6 | |
| 8 | 2017 | 8 | |
| 9 | 2016 | 36 | |
| 10 | 2015 | 4 | |
| 11 | 2015 | 43 | |
| 12 | 2015 | 10 | |
| 13 | 2014 | 6 | |
| 14 | 2013 | 11 | |
| 15 | 2012 | 35 | |
| 16 | Characterization of primary human hepatocytes, HepG2 cells, and HepaRG cells at the mRNA level and CYP activity in response to inducers and their predictivity for the detection of human hepatotoxinsbreakdown → | 2012 | 551 |
| 17 | 2012 | 16 | |
| 18 | 2007 | 137 | |
| 19 | 2003 | 60 | |
| 20 | 1999 | 63 |
About Hugues Chanteux
Hugues Chanteux is a scholar working on Pharmacology, Pediatrics, Perinatology and Child Health and Psychiatry and Mental health, having authored 39 papers that have together received 1.7k indexed citations. Recurring topics across this work include Pharmacological Effects and Toxicity Studies (15 papers), Drug Transport and Resistance Mechanisms (12 papers), Epilepsy research and treatment (12 papers), Pharmacogenetics and Drug Metabolism (9 papers), Antibiotics Pharmacokinetics and Efficacy (8 papers), Neuroscience and Neuropharmacology Research (5 papers), Drug-Induced Hepatotoxicity and Protection (3 papers) and Pharmaceutical studies and practices (3 papers). The work is most often cited by research in Molecular Medicine (162 citations), Pharmacology (276 citations) and Hepatology (171 citations). Hugues Chanteux has collaborated with scholars based in Belgium, United Kingdom and United States. Frequent co-authors include Brigitte Gerin, Paul M. Tulkens, Marie‐Paule Mingeot‐Leclercq, Franck A. Atienzar, Karen Tilmant, B. O. Depelchin, Helga H.J. Gerets, Stéphane Dhalluin, Françoise Van Bambeke and Jean‐Marie Nicolas. Their work appears in journals such as Neurology, Gut and Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.